GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MedCap AB (OSTO:MCAP) » Definitions » Cyclically Adjusted FCF per Share

MedCap AB (OSTO:MCAP) Cyclically Adjusted FCF per Share : kr5.56 (As of Mar. 2025)


View and export this data going back to 2004. Start your Free Trial

What is MedCap AB Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

MedCap AB's adjusted free cash flow per share for the three months ended in Mar. 2025 was kr2.752. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is kr5.56 for the trailing ten years ended in Mar. 2025.

During the past 12 months, MedCap AB's average Cyclically Adjusted FCF Growth Rate was 47.90% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 36.80% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 25.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of MedCap AB was 36.80% per year. The lowest was 14.30% per year. And the median was 18.80% per year.

As of today (2025-05-13), MedCap AB's current stock price is kr457.00. MedCap AB's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was kr5.56. MedCap AB's Cyclically Adjusted Price-to-FCF of today is 82.19.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of MedCap AB was 147.07. The lowest was 60.00. And the median was 98.86.


MedCap AB Cyclically Adjusted FCF per Share Historical Data

The historical data trend for MedCap AB's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedCap AB Cyclically Adjusted FCF per Share Chart

MedCap AB Annual Data
Trend Apr15 Apr16 Apr17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.94 2.11 2.24 3.12 5.40

MedCap AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.76 4.31 4.58 5.40 5.56

Competitive Comparison of MedCap AB's Cyclically Adjusted FCF per Share

For the Medical Devices subindustry, MedCap AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedCap AB's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MedCap AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where MedCap AB's Cyclically Adjusted Price-to-FCF falls into.


;
;

MedCap AB Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, MedCap AB's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=2.752/132.8245*132.8245
=2.752

Current CPI (Mar. 2025) = 132.8245.

MedCap AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201504 -5.278 99.941 -7.015
201507 1.861 100.027 2.471
201510 -0.460 100.301 -0.609
201601 -2.460 99.931 -3.270
201604 -1.009 100.732 -1.330
201607 -0.257 101.080 -0.338
201610 0.338 101.485 0.442
201701 2.151 101.326 2.820
201704 1.035 102.615 1.340
201707 -0.017 103.301 -0.022
201710 0.555 103.202 0.714
201803 1.311 103.962 1.675
201806 -0.239 104.875 -0.303
201809 -0.052 105.679 -0.065
201812 3.198 105.912 4.011
201903 1.866 105.886 2.341
201906 0.216 106.742 0.269
201909 0.676 107.214 0.837
201912 0.297 107.766 0.366
202003 1.605 106.563 2.001
202006 2.870 107.498 3.546
202009 -0.196 107.635 -0.242
202012 2.121 108.296 2.601
202103 0.682 108.360 0.836
202106 1.412 108.928 1.722
202109 1.006 110.338 1.211
202112 0.642 112.486 0.758
202203 2.641 114.825 3.055
202206 1.027 118.384 1.152
202209 2.465 122.296 2.677
202212 -3.343 126.365 -3.514
202303 3.001 127.042 3.138
202306 1.998 129.407 2.051
202309 3.506 130.224 3.576
202312 4.197 131.912 4.226
202403 4.985 132.205 5.008
202406 3.661 132.716 3.664
202409 3.951 132.304 3.967
202412 7.112 132.987 7.103
202503 2.752 132.825 2.752

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


MedCap AB  (OSTO:MCAP) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

MedCap AB's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=457.00/5.56
=82.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of MedCap AB was 147.07. The lowest was 60.00. And the median was 98.86.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


MedCap AB Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of MedCap AB's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


MedCap AB Business Description

Traded in Other Exchanges
N/A
Address
Sundbybergsvagen 1, Solna, SWE, 171 73
MedCap AB acquires and develops profitable, market-leading niche companies in the Nordic life science industry. It is diversified into two business areas namely Medical technology and Specialist medicines. Medical Technology mainly develops and sells various medical technology products and services. Its Specialist medicines develop and sell medicines within the regulatory classes of registered, extemporaneous and licensed medicines.

MedCap AB Headlines